Robert Brunhouse, Ph.D. is a consultant at Russell Biotech, Inc., where he is responsible for  manufacturing final product. Dr. Brunhouse brings extensive industrial and academic experience in immunochemistry and microparticle production to the company. At present, he is the Director of Protein Science at Innovative Cell Technologies, Inc., of San Diego. Prior to joining Innovative Cell Technologies, he held positions in R&D at Qualigen and Accumetrics that emphasized cell-and particle based diagnostics. In 1984 Dr. Brunhouse joined Coulter’s Immunology Division, a month after Dr. Russell. Under the direction of Dr. Russell, he spearheaded the production of the T8 cell lines and antibody used in the first clinical trials of Eligix’s cell separation technique to abrogate Graft versus Host Disease. Dr. Brunhouse also invented and developed the manufacturing and testing methods for a particle-based quantitative CD4 count using a hemacytometer. He received his Ph.D. at the Johns Hopkins University.

Michael Musick, Ph. D., a consultant with Russell Biotech, Inc, is responsible for the manufacture and characterization of the company’s ferromagnetic particles, and is a co-inventor of the company’s ferromagnetic selection technology. Currently employed in the field of micro and nano particles, Dr. Musick has synthesized numerous particles and surface treatments. His efforts in analytical research are diverse ranging from the fields of micro, and nano structural analysis, surface characterization, material property measurement, and chemical coatings to clinical diagnostics and genetic screening. He received his B.S. in chemistry from the University of Pittsburgh in 1994 and a Ph.D. from the Pennsylvania State University in 1999 studying nanostructure assemblies and new immunological detection strategies. He is the co-author of 14 scientific publications and a co-inventor on 7 patents.

Judith H. Smith, Ph.D., is an independent consultant with Russell Biotech, Inc, responsible for product marketing and web design. Dr. Smith was previously employed by Beckman Coulter, Inc., where she held several positions including scientific liaison for products designed to detect enzyme activity using flow cytometric evaluation, manager of the technical support group for coagulation products, and scientist in R&D for flow cytometry products. She also has eight years experience in clinical labs performing diagnostic testing in the field of immunology, specializing in characterization of leukemias/lymphomas,  DNA analysis of solid tumors, and detection of microbiological pathogens using PCR. Dr. Smith received her Ph.D. in Immunology and Medical Microbiology from the University of South Florida College of Medicine.

Nancye Files is a marketing consultant at Russell Biotech, Inc.  Ms. Files has had extensive industry experience in the research and diagnostic markets with leading edge technologies for cell identification and analysis primarily in immunology, oncology, and genetics. She has held various marketing positions in both start up companies (Oncor, IMI ) and major diagnostic companies ( Coulter and Becton Dickinson Immunocytometry Systems), with both national and international responsibilities. Most recently Ms. Files was Senior Director of Marketing at Immunicon.  Prior to pursuing a career in marketing in the medical diagnostic field, Ms. Files spent several years working in academic research in immunology at Harvard Medical School and The Rockefeller University.  She received a BA degree in Biology from the University of Pennsylvania.